Treatment of Glycogen Storage Disease Type IV with Neurogenic Bladder and Urinary Voiding Symptoms
Glycogen storage disease type IV can be associated with neurogenic bladder dysfunction, giving rise to a cluster of lower urinary tract symptoms that require structured clinical management.
Clinical Scenario
This protocol applies to patients with Glycogen storage disease type IV who present with:
- Neurogenic bladder
- Urinary hesitancy
- Urinary straining
- Slow urinary stream
- Urinary emptying difficulty
Treatment Approach
When conservative voiding strategies are insufficient, the protocol includes reconstructive surgical procedures as part of a defined management pathway. The full regimen and decision sequence are available via the link below.
References
- For patients with hesitancy, straining, slow stream, or emptying difficulties, first-line treatments include timed voiding, double voiding (i.e., attempting to void again immediately after going), optimizing bowel function, and pelvic floor muscle exercises geared toward improving relaxation and tone (see Section 5.6).
- Occasionally, reconstructive procedures to augment the bladder and build a catheterizable channel may be needed.
DOI: 10.1016/j.ymgme.2023.107525
View source ↗